Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-006860
Filing Date
2016-07-28
Accepted
2016-07-28 08:01:06
Documents
63
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20160630x10q.htm 10-Q 2029797
2 EX-31.1 alks-20160630ex3118d42c3.htm EX-31.1 42934
3 EX-31.2 alks-20160630ex31238d2ec.htm EX-31.2 43677
4 EX-32.1 alks-20160630ex321e7b002.htm EX-32.1 20401
  Complete submission text file 0001558370-16-006860.txt   7100342

Data Files

Seq Description Document Type Size
5 EX-101.INS alks-20160630.xml EX-101.INS 1652755
6 EX-101.SCH alks-20160630.xsd EX-101.SCH 37599
7 EX-101.CAL alks-20160630_cal.xml EX-101.CAL 67667
8 EX-101.DEF alks-20160630_def.xml EX-101.DEF 99964
9 EX-101.LAB alks-20160630_lab.xml EX-101.LAB 388405
10 EX-101.PRE alks-20160630_pre.xml EX-101.PRE 255957
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 161788418
SIC: 2834 Pharmaceutical Preparations